• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

八乙酰蔗糖熔融物作为口服改性释放剂型,用于以稳定无定形形式传递难溶性化合物。

Melts of Octaacetyl Sucrose as Oral-Modified Release Dosage Forms for Delivery of Poorly Soluble Compound in Stable Amorphous Form.

机构信息

Faculty of Pharmacy, Department of Drug Form Technology, Wroclaw Medical University, Borowska 211A, 50-556, Wroclaw, Poland.

Department of Pharmacognosy and Phytochemistry, Medical University of Silesia in Katowice, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, ul. Jagiellonska 4, 41-200, Sosnowiec, Poland.

出版信息

AAPS PharmSciTech. 2018 Feb;19(2):951-960. doi: 10.1208/s12249-017-0912-0. Epub 2017 Nov 2.

DOI:10.1208/s12249-017-0912-0
PMID:29098644
Abstract

The presented work describes the formulation and characterization of modified release glassy solid dosage forms (GSDFs) containing an amorphous nifedipine, as a model BCS (Biopharmaceutical Classification System) class II drug. The GSDFs were prepared by melting nifedipine together with octaacetyl sucrose. Dissolution profiles, measured under standard and biorelevant conditions, were compared to those obtained from commercially available formulations containing nifedipine such as modified release (MR) tablets and osmotic release oral system (OROS). The results indicate that the dissolution profiles of the GSDFs with nifedipine are neither affected by the pH of the dissolution media, type and concentration of surfactants, nor by simulated mechanical stress of biorelevant intensity. Furthermore, it was found that the dissolution profiles of the novel dosage forms were similar to the profiles obtained from the nifedipine OROS. The formulation of GSDFs is relatively simple, and the dosage forms were found to have favorable dissolution characteristics.

摘要

本工作描述了含有非那吡啶的改良释放玻璃状固体剂型(GSDF)的配方和特性,作为模型 BCS(生物药剂学分类系统)II 类药物。GSDF 通过将非那吡啶与八乙酰蔗糖熔融制备。在标准和生物相关条件下测量的溶解曲线与从含有非那吡啶的市售制剂(如缓释(MR)片剂和渗透释放口服系统(OROS))获得的那些进行了比较。结果表明,含有非那吡啶的 GSDF 的溶解曲线不受溶解介质 pH 值、类型和浓度的表面活性剂以及生物相关强度的模拟机械应力的影响。此外,发现新型剂型的溶解曲线与非那吡啶 OROS 获得的曲线相似。GSDF 的配方相对简单,并且发现这些剂型具有良好的溶解特性。

相似文献

1
Melts of Octaacetyl Sucrose as Oral-Modified Release Dosage Forms for Delivery of Poorly Soluble Compound in Stable Amorphous Form.八乙酰蔗糖熔融物作为口服改性释放剂型,用于以稳定无定形形式传递难溶性化合物。
AAPS PharmSciTech. 2018 Feb;19(2):951-960. doi: 10.1208/s12249-017-0912-0. Epub 2017 Nov 2.
2
Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.溶出介质 pH 值和模拟胃肠道收缩对硝苯地平缓释片药物释放的影响。
J Pharm Sci. 2019 Mar;108(3):1189-1194. doi: 10.1016/j.xphs.2018.10.014. Epub 2018 Oct 19.
3
Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine.基于生物相关性的溶出试验能否预测剂型依赖性食物效应?以硝苯地平控释片为例。
Eur J Pharm Biopharm. 2016 Aug;105:193-202. doi: 10.1016/j.ejpb.2016.06.010. Epub 2016 Jun 15.
4
Factors affecting the release of nifedipine from a swellable elementary osmotic pump.影响硝苯地平从可膨胀单室渗透泵中释放的因素。
Drug Deliv. 2008 Jan;15(1):43-8. doi: 10.1080/10717540701829028.
5
Application of biorelevant saliva-based dissolution for optimisation of orally disintegrating formulations of felodipine.基于生物相关唾液的溶出度在优化非洛地平口腔崩解片中的应用。
Int J Pharm. 2019 Jan 30;555:228-236. doi: 10.1016/j.ijpharm.2018.11.051. Epub 2018 Nov 19.
6
Potential prediction of formulation performance in paediatric patients using biopharmaceutical tools and simulation of clinically relevant administration scenarios of nifedipine and lorazepam.利用生物制药工具预测儿科患者的配方性能,并模拟硝苯地平和劳拉西泮的临床相关给药方案。
Br J Clin Pharmacol. 2019 Aug;85(8):1728-1739. doi: 10.1111/bcp.13956. Epub 2019 Jun 18.
7
Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.共处理水对含 N-乙酰半胱氨酸口服制剂体内性能的影响:采用动态开放流动通过测试装置的体外方法。
Mol Pharm. 2017 Dec 4;14(12):4272-4280. doi: 10.1021/acs.molpharmaceut.7b00763. Epub 2017 Nov 3.
8
Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Nifedipine.速释固体口服剂型的生物豁免专著:硝苯地平
J Pharm Sci. 2015 Oct;104(10):3289-98. doi: 10.1002/jps.24560. Epub 2015 Jul 6.
9
A biorelevant dissolution stress test device - background and experiences.生物相关溶出度测试装置——背景与经验
Expert Opin Drug Deliv. 2010 Nov;7(11):1251-61. doi: 10.1517/17425247.2010.527943.
10
Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses.使用不同溶出度测试装置对硝苯地平一日一次缓释制剂获得的溶出曲线进行比较。
Eur J Pharm Sci. 2009 Sep 10;38(2):147-55. doi: 10.1016/j.ejps.2009.06.010. Epub 2009 Jul 8.

引用本文的文献

1
Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial.用于首次人体临床试验的含新型GPR40激动剂的缓释片生物药剂学性质的开发与生物预测评估
Pharmaceutics. 2021 May 28;13(6):804. doi: 10.3390/pharmaceutics13060804.